Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/23/1998 | EP0607222B1 Dendrimeric polychelants |
12/23/1998 | EP0591528B1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND ANTI-INFLAMMATORY CONTAINING THE SAME |
12/23/1998 | EP0527851B1 1h-substituted-1,2,4-triazole compounds for treatment of cardiovascular disorders |
12/23/1998 | EP0494914B1 2-spirocyclopropyl cephalosporin derivatives and processes for the preparation thereof |
12/23/1998 | CN2301204Y Female sterilization film |
12/23/1998 | CN1202934A Delivery of biologically active polypeptides |
12/23/1998 | CN1202931A Tumour vaccine and process for the preparation thereof |
12/23/1998 | CN1202907A Cyclopeptide derivatives |
12/23/1998 | CN1202905A Parainfluenza virus glycoproteins and vaccines |
12/23/1998 | CN1202904A Cyclopeptolides |
12/23/1998 | CN1202903A Targeted cytotoxic anthracycline analogs |
12/23/1998 | CN1202902A Thrombin inhibitors |
12/23/1998 | CN1202901A Phosphonic acid derivatives with metallopeptidase inhibitory activity |
12/23/1998 | CN1202900A Inhibition of tumor growth by antisense oligonucleotides for IL-8 and Il-8 receptor |
12/23/1998 | CN1202896A Purine derivatives and processes for their preparation |
12/23/1998 | CN1202895A Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalluproteinass (MMP) and/or tumour necrosis factor (TNF) |
12/23/1998 | CN1202894A Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases |
12/23/1998 | CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists |
12/23/1998 | CN1202891A New quinoxalindione derivatives, their preparation and use in medicaments |
12/23/1998 | CN1202890A Amino acid derivatives, the preparation and use thereof as endothelia antagonists |
12/23/1998 | CN1202887A Tetrahydroquinolines as NMDA antagonists |
12/23/1998 | CN1202886A 3-spiro-indolin-2-one derivatives, its preparing method and its medicinal compounds |
12/23/1998 | CN1202885A 25-hydroxy-16-one-26,27-bishomo-cholecalciferols |
12/23/1998 | CN1202882A New LH-RH antigonists with improved effectiveness |
12/23/1998 | CN1202834A Hollow-tube brachytherapy device |
12/23/1998 | CN1202829A Method for preserving microoganisms |
12/23/1998 | CN1202828A Substituted pyrzolyl benzenesulfonanides for use in veterinary |
12/23/1998 | CN1202827A 1,2,4-benzotriazine oxides formulations |
12/23/1998 | CN1202826A Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral scherosis |
12/23/1998 | CN1202825A Protein kinase C inhibitor |
12/23/1998 | CN1202824A Combinational therapeutic methods employing nitric oxide scavengers |
12/23/1998 | CN1202823A Hydrolysis-optimized liplid emulsions and use thereof |
12/23/1998 | CN1202822A Use of a THF alpha antagonist for treating neurogenic skin redness |
12/23/1998 | CN1202821A Compositions and methods for buccal delivery of pharmaceutical agent |
12/23/1998 | CN1202818A Solubilisation method |
12/23/1998 | CN1202799A Method for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains |
12/23/1998 | CN1202493A Intermediate of doramectin for antiparastic chemical and its preparing method |
12/23/1998 | CN1202490A Process for preparing high content d-alpha type vitamin E |
12/23/1998 | CN1202488A Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof |
12/23/1998 | CN1202359A Medicine for preventing sexual disease |
12/23/1998 | CN1202358A Medicinal liquid and ointment for curing ache folliculitis and eczema |
12/23/1998 | CN1202357A Medicine for curing sexual disease |
12/23/1998 | CN1041311C Method for preparing benzopyran and related LTB4 antagonists |
12/23/1998 | CN1041310C Process for obtaining 10-deacetylbaccatin III |
12/23/1998 | CN1041309C Method for preparing piperidine derivatives |
12/23/1998 | CN1041275C Use of acetoxy benzoic acids in medicine for curing tinea corporis and bromhidrosis |
12/23/1998 | CA2698626A1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor |
12/23/1998 | CA2549864A1 Treatment of diabetes with thiazolidinedione and metformin |
12/23/1998 | CA2430623A1 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
12/23/1998 | CA2295207A1 Hammerhead ribozymes with extended cleavage rule |
12/23/1998 | CA2294888A1 4-haloalkyl-3- heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyrimidines, processes for their preparation, compositions comprising them, and their use as pesticides |
12/23/1998 | CA2294724A1 Method for producing medicaments containing hmg-coa-reductase inhibitors |
12/23/1998 | CA2294593A1 Agent for diagnosing and treating malignant tumors |
12/23/1998 | CA2294591A1 Alpha 1a adrenergic receptor antagonists |
12/23/1998 | CA2294590A1 Alpha 1a adrenergic receptor antagonists |
12/23/1998 | CA2294589A1 Composition for controlling mood disorders in healthy individuals |
12/23/1998 | CA2294549A1 Heterocyclic substituted piperidines and uses thereof |
12/23/1998 | CA2294519A1 Peptides and compounds that bind to the il-5 receptor |
12/23/1998 | CA2294443A1 Polymer comprising unsaturated ester units and pharmaceutical and cosmetic compositions thereof |
12/23/1998 | CA2294398A1 An itraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same |
12/23/1998 | CA2294379A1 3-benzylpiperidine |
12/23/1998 | CA2294349A1 Alpha 1aadrenergic receptor antagonists |
12/23/1998 | CA2294346A1 Alpha 1a adrenergic receptor antagonists |
12/23/1998 | CA2294344A1 Alpha 1a adrenergic receptor antagonists |
12/23/1998 | CA2294281A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
12/23/1998 | CA2294141A1 Treatment of diabetes with rosiglitazone and insulin |
12/23/1998 | CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds |
12/23/1998 | CA2294134A1 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor |
12/23/1998 | CA2294047A1 Crystalline roxifiban |
12/23/1998 | CA2294011A1 Use of draflazine-analogues for treating pain |
12/23/1998 | CA2293482A1 Carboxy piperidylacetamide tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors) |
12/23/1998 | CA2293449A1 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
12/23/1998 | CA2293418A1 Quinoline-indole antimicrobial agents, uses and compositions related thereto |
12/23/1998 | CA2293408A1 Alpha 1a adrenergic receptor antagonists |
12/23/1998 | CA2292883A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
12/23/1998 | CA2292608A1 Therapeutic systems for activation prodrugs |
12/23/1998 | CA2292604A1 Pyrrolidine carboxylic acid derivatives as endothelin antagonists |
12/23/1998 | CA2292457A1 Use of a pharmaceutical composition in the treatment of traumatic arthritis in horses |
12/23/1998 | CA2291442A1 Novel guanidine mimics as factor xa inhibitors |
12/23/1998 | CA2290982A1 Inhibitors of factor xa with a neutral p1 specificity group |
12/23/1998 | CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
12/23/1998 | CA2241164A1 Apo b-secretion/mtp inhibitor hydrochloride salt |
12/22/1998 | US5852210 Cinnamic acid derivatives |
12/22/1998 | US5852204 Pyrrolo 3,2-b-!-carbazoles and 1H 1!benzothieno 2,3-f! indoles having anti-tumor activity |
12/22/1998 | US5852195 Pyranone compounds useful to treat retroviral infections |
12/22/1998 | US5852190 Diazepinoindoles as phosphodiesterase IV inhibitors |
12/22/1998 | US5852188 Oligonucleotides having chiral phosphorus linkages |
12/22/1998 | US5852180 Chemical synthesis of 6-O-alkyl erythromycin A |
12/22/1998 | US5852176 Antibodies to receptors for human interleukin-12 |
12/22/1998 | US5852174 Antibodies to liver derived receptors for advanced glycosylation endproducts and uses therefor |
12/22/1998 | US5852060 Antipsoriatic compositions, method of making, and method of using |
12/22/1998 | US5852059 Use of droloxifene for the treatment of protastic disease, endometriosis and obesity |
12/22/1998 | US5852058 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
12/22/1998 | US5852057 Anticarcinogenic drug composition |
12/22/1998 | US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
12/22/1998 | US5852055 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof |
12/22/1998 | US5852053 Use of 2-4-amino-4-(4-fluorobenzylamino) (-1-ethoxy-carbonylaminobenzene for the prophylaxis and treatment of the neurodegenerative disorders |
12/22/1998 | US5852052 Treatment of lyso paf-mediated mental or neuronal disorders with lyso paf or paf antagonists and procedure for determining their efficacy |
12/22/1998 | US5852050 Preparation for treating wounds or hemorrhoids |
12/22/1998 | US5852049 Aromatic ethers derived from indoles which are useful as medicaments |